Results 211 to 220 of about 34,622 (305)

Potential of endophytic Beauveria bassiana against Coraebus (Coleoptera: Buprestidae) oak borers

open access: yesPest Management Science, EarlyView.
This study demonstrates that an endophytic, oak‐associated strain of Beauveria bassiana exhibits adaptations to Quercus plants and potential against Coraebus boring beetles, supported by distinctive biological traits. Abstract BACKGROUND Oak borers in the genus Coraebus, including the bark‐ and the wood‐boring beetles C. florentinus and C. undatus, are
Walaa Morda   +5 more
wiley   +1 more source

Glucosinolate hydrolysis products suppress entomopathogenic nematodes in vitro but do not protect sequestering flea beetle larvae in vivo

open access: yesPest Management Science, EarlyView.
The flea beetle's glucosinolate‐based chemical defense fails to protect larvae from nematode infection. However, the defense inhibits the nematode's symbiotic bacteria, thereby potentially impairing nematode reproduction and biocontrol success. Abstract BACKGROUND The efficacy of entomopathogenic nematodes (EPNs) in the biological control of insect ...
Johannes Körnig   +9 more
wiley   +1 more source

Mirikizumab pharmacokinetics and exposure–response in pediatric patients with moderate‐to‐severe ulcerative colitis

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 474-485, March 2025.
Abstract Mirikizumab is a p19‐directed anti‐interleukin‐23 antibody approved for the treatment of adults with moderate‐to‐severe ulcerative colitis (UC). Here, we report the first data of mirikizumab pharmacokinetics (PK) and exposure–response (E/R) relationships in pediatric participants (aged 2 to <18 years weighing >10 kg) with moderate‐to‐severe UC
Yuki Otani   +5 more
wiley   +1 more source

Can Patient Education Lead the Way? Head‐To‐Head Comparison of EXACT and CERT for Early Recognition of Acute COPD Exacerbations

open access: yesRespirology, EarlyView.
Daily head‐to‐head comparison of EXACT vs. CERT for early detection of acute COPD exacerbations. Both tools accurately identified exacerbations at diagnosis (AUC≈0.9), but CERT detected worsening one day earlier (p = 0.006). CERT's simplicity and free access support rapid patient self‐monitoring and may enable timely intervention.
Rainer Gloeckl   +9 more
wiley   +1 more source

A Systematic Review of Discrete Choice Experiments on Preferences for COVID-19 Vaccinations. [PDF]

open access: yesPatient
Hinzpeter EL   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy